SPV-30 may offer CD4 increase. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


SPV-30 may offer CD4 increase. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

Posit Aware. 1995 May/Jun;:7. Unique Identifier : AIDSLINE AIDS/95700399

Abstract: Dr. Luc Montagnier has been given permission by French health officials to proceed with a phase II/III trial of SPV-30, an herbal treatment derived from the European boxwood tree. The product, available as an over-the-counter dietary supplement, is not considered a drug and therefore does not require approval by the Food and Drug Administration (FDA). Preliminary data suggest that SPV-30 is effective in increasing CD4 and CD8 counts while decreasing viral load in patients with HIV. About 200 HIV-positive Americans have already enrolled in the U.S. study. Those interested may receive a free six-month supply of SPV-30 in exchange for filling out a questionnaire and sending in complete blood work and a battery of tests. For more information about the trial, contact Boston AIDS activist David Stokes at (614) 424-9195.
Keywords: Clinical Trials *CD4 Lymphocyte Count Double-Blind Method Human HIV Infections/BLOOD/*THERAPY Placebos Plant Extracts/*THERAPEUTIC USE *Plants, Medicinal NEWSLETTER ARTICLEKWDclinicaltrialsKWDcd4lymphocytecountdouble-blindmethodhumanhivinfections/blood/KWDtherapyplacebosplantextracts/KWDtherapeuticuseKWDplants,medicinalnewsletterarticle
951230
M95C3195

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .